Aull & Monroe Investment Management Corp Haleon PLC Transaction History

Aull & Monroe Investment Management Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	SELL	$8.02 - $8.67 $5,614 - $6,069	-700 Reduced 5.19%	12,784 $108,000
Q4 2023 Jan 25, 2024	SELL	$7.78 - $8.62 $20,228 - $22,411	-2,600 Reduced 16.17%	13,484 $110,000
Q3 2023 Nov 13, 2023	BUY	$7.85 - $8.94 $1,821 - $2,074	232 Added 1.46%	16,084 $133,000
Q2 2023 Jul 24, 2023	SELL	$8.04 - $9.0 $3,642 - $4,077	-453 Reduced 2.78%	15,852 $132,000
Q1 2023 May 12, 2023	SELL	$7.57 - $8.37 $1,514 - $1,673	-200 Reduced 1.21%	16,305 $132,000
Q4 2022 Feb 07, 2023	SELL	$5.96 - $8.06 $2,068 - $2,796	-347 Reduced 2.06%	16,505 $132,000
Q3 2022 Nov 10, 2022	BUY	$5.63 - $7.5 $94,876 - $126,390	16,852 New	16,852 $103,000

639

412M

149K

16K

Ticker HLN
Exchange
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 4,617,290,240
Market Cap $44.8B
Description
Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...

Get notified when there are updates to the investment portfolio of Aull & Monroe Investment Management Corp, based on Form 13F filings with the SEC.

Stay updated on Aull & Monroe Investment Management Corp with notifications on news.